Abstract
Recombinant severe acute respiratory syndrome (SARS) nucleocapsid and spike protein-based immunoglobulin G immunoassays were developed and evaluated. Our assays demonstrated high sensitivity and specificity to the SARS coronavirus in sera collected from patients as late as 2 years postonset of symptoms. These assays will be useful not only for routine SARS coronavirus diagnostics but also for epidemiological and antibody kinetic studies.
Original language | English (US) |
---|---|
Pages (from-to) | 331-333 |
Number of pages | 3 |
Journal | Clinical and Vaccine Immunology |
Volume | 14 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2007 |
Externally published | Yes |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Clinical Biochemistry
- Microbiology (medical)